Cargando…

Atypical presentation of giant cell arteritis in a patient with vertebrobasilar stroke: A case report

RATIONALE: Giant cell arteritis (GCA) is known to present with typical manifestations like temporal headache and visual abnormalities. However, several cases with atypical manifestations were reported. Stroke occurs in 3% to 7% of patients with GCA. PATIENT CONCERNS: A 67-year-old male patient with...

Descripción completa

Detalles Bibliográficos
Autores principales: Elhfnawy, Ahmed Mohamed, Bieber, Michael, Schliesser, Mira, Kraft, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709119/
https://www.ncbi.nlm.nih.gov/pubmed/31393385
http://dx.doi.org/10.1097/MD.0000000000016737
_version_ 1783446135401086976
author Elhfnawy, Ahmed Mohamed
Bieber, Michael
Schliesser, Mira
Kraft, Peter
author_facet Elhfnawy, Ahmed Mohamed
Bieber, Michael
Schliesser, Mira
Kraft, Peter
author_sort Elhfnawy, Ahmed Mohamed
collection PubMed
description RATIONALE: Giant cell arteritis (GCA) is known to present with typical manifestations like temporal headache and visual abnormalities. However, several cases with atypical manifestations were reported. Stroke occurs in 3% to 7% of patients with GCA. PATIENT CONCERNS: A 67-year-old male patient with known hypertension presented with somnolence, disorientation and mild bilateral limb ataxia. The magnetic resonance imaging showed multiple acute infarctions in the territory of the vertebrobasilar system with occlusion of the left vertebral artery. DIAGNOSIS: Ten months later, during a routine neurovascular follow-up, recanalization of the left vertebral artery was observed and a hypoechoic concentric “halo” sign around both vertebral arteries, mainly on the left side was evident. On further examination of the superficial temporal artery, a hypoechoic concentric “halo” sign was also found, which—along with increased inflammatory markers—raised suspicion about GCA. Classical GCA features like headache, temporal tenderness or amaurosis fugax were not present. Repeated in-depth diagnostic work-up including 48 hours Holter-ECG did not reveal another stroke etiology. INTERVENTIONS: Intravenous Methylprednisolone 250 mg/d was immediately started and after 6 days the dose was tapered to 80 mg/d. The patient was discharged on a tapering scheme with the recommendation to start azathioprine. Additionally, we placed the patient on acetylsalicylic acid 100 mg/d and clopidogrel 75 mg/d. However, the patient was not compliant to treatment; he stopped prednisolone early and did not start azathioprine. OUTCOMES: The inflammatory markers were markedly reduced at the beginning of the treatment. After stopping the immunosuppressive medications, the inflammatory markers were once again increased. Three months later, the patient developed bilateral middle cerebral artery and right occipital lobe infarctions. LESSONS: In patients with cryptogenic vertebrobasilar strokes, GCA may be considered in the differential diagnosis, especially if the inflammatory markers are increased.
format Online
Article
Text
id pubmed-6709119
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-67091192019-10-01 Atypical presentation of giant cell arteritis in a patient with vertebrobasilar stroke: A case report Elhfnawy, Ahmed Mohamed Bieber, Michael Schliesser, Mira Kraft, Peter Medicine (Baltimore) Research Article RATIONALE: Giant cell arteritis (GCA) is known to present with typical manifestations like temporal headache and visual abnormalities. However, several cases with atypical manifestations were reported. Stroke occurs in 3% to 7% of patients with GCA. PATIENT CONCERNS: A 67-year-old male patient with known hypertension presented with somnolence, disorientation and mild bilateral limb ataxia. The magnetic resonance imaging showed multiple acute infarctions in the territory of the vertebrobasilar system with occlusion of the left vertebral artery. DIAGNOSIS: Ten months later, during a routine neurovascular follow-up, recanalization of the left vertebral artery was observed and a hypoechoic concentric “halo” sign around both vertebral arteries, mainly on the left side was evident. On further examination of the superficial temporal artery, a hypoechoic concentric “halo” sign was also found, which—along with increased inflammatory markers—raised suspicion about GCA. Classical GCA features like headache, temporal tenderness or amaurosis fugax were not present. Repeated in-depth diagnostic work-up including 48 hours Holter-ECG did not reveal another stroke etiology. INTERVENTIONS: Intravenous Methylprednisolone 250 mg/d was immediately started and after 6 days the dose was tapered to 80 mg/d. The patient was discharged on a tapering scheme with the recommendation to start azathioprine. Additionally, we placed the patient on acetylsalicylic acid 100 mg/d and clopidogrel 75 mg/d. However, the patient was not compliant to treatment; he stopped prednisolone early and did not start azathioprine. OUTCOMES: The inflammatory markers were markedly reduced at the beginning of the treatment. After stopping the immunosuppressive medications, the inflammatory markers were once again increased. Three months later, the patient developed bilateral middle cerebral artery and right occipital lobe infarctions. LESSONS: In patients with cryptogenic vertebrobasilar strokes, GCA may be considered in the differential diagnosis, especially if the inflammatory markers are increased. Wolters Kluwer Health 2019-08-09 /pmc/articles/PMC6709119/ /pubmed/31393385 http://dx.doi.org/10.1097/MD.0000000000016737 Text en Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle Research Article
Elhfnawy, Ahmed Mohamed
Bieber, Michael
Schliesser, Mira
Kraft, Peter
Atypical presentation of giant cell arteritis in a patient with vertebrobasilar stroke: A case report
title Atypical presentation of giant cell arteritis in a patient with vertebrobasilar stroke: A case report
title_full Atypical presentation of giant cell arteritis in a patient with vertebrobasilar stroke: A case report
title_fullStr Atypical presentation of giant cell arteritis in a patient with vertebrobasilar stroke: A case report
title_full_unstemmed Atypical presentation of giant cell arteritis in a patient with vertebrobasilar stroke: A case report
title_short Atypical presentation of giant cell arteritis in a patient with vertebrobasilar stroke: A case report
title_sort atypical presentation of giant cell arteritis in a patient with vertebrobasilar stroke: a case report
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709119/
https://www.ncbi.nlm.nih.gov/pubmed/31393385
http://dx.doi.org/10.1097/MD.0000000000016737
work_keys_str_mv AT elhfnawyahmedmohamed atypicalpresentationofgiantcellarteritisinapatientwithvertebrobasilarstrokeacasereport
AT biebermichael atypicalpresentationofgiantcellarteritisinapatientwithvertebrobasilarstrokeacasereport
AT schliessermira atypicalpresentationofgiantcellarteritisinapatientwithvertebrobasilarstrokeacasereport
AT kraftpeter atypicalpresentationofgiantcellarteritisinapatientwithvertebrobasilarstrokeacasereport